Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

NCT00706810 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00706810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00706810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
September 30, 2015
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, cancer, meningioma